Biologic augmentation in rotator cuff repair: current evidence and future directions.

Area of Science:

• Orthopedic Surgery
• Regenerative Medicine
• Biomaterials Science

Background:

• Rotator cuff repairs (RCRs) have variable success rates (16-94%) despite surgical advancements.
• High failure rates and retear incidence remain significant clinical challenges in RCR.

Purpose of the Study:

• To review current evidence on biologic augmentation strategies for RCR.
• To assess the efficacy of platelet-rich plasma, stem cells, and scaffolds in improving RCR healing and reducing retear rates.

Main Methods:

• Systematic review of preclinical and clinical studies on biologic augmentation in RCR.
• Analysis of outcomes related to structural healing, functional scores, and retear rates.
• Exploration of emerging modalities like gene therapy and amniotic membrane products.

Main Results:

• Biologic augmentation shows potential for enhanced structural healing and functional recovery in RCR.
• Current research yields mixed results due to a lack of standardized protocols for application, concentration, and surgical technique.
• Heterogeneity in outcomes necessitates further investigation into optimal use of these biologic agents.

Conclusions:

• Biologic augmentation holds significant promise for optimizing RCR outcomes.
• Standardized protocols and large-scale human trials are crucial for clinical effectiveness and widespread adoption.
• Future research should focus on establishing evidence-based guidelines for biologic augmentation in RCR.